Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India

Breast cancer is a public health challenge globally as well as in India. Improving outcome and cure requires appropriate biomarker testing to assign risk and plan treatment. Because it is documented that significant ethnic and geographical variations in biological and genetic features exist worldwid...

Descripción completa

Detalles Bibliográficos
Autores principales: Parikh, Purvish M., Bhattacharyya, Gouri Shankar, Biswas, Ghanshyam, Krishnamurty, Arvind, Doval, Dinesh, Heroor, Anil, Sharma, Sanjay, Deshpande, Ramakant, Chaturvedi, Harit, Somashekhar, S. P., Babu, Govind, Reddy, G. Krishna, Sarkar, Diptendra, Desai, Chirag, Malhotra, Hemant, Rohagi, Nitesh, Bapna, Ajay, Alurkar, S. S., Krishna, Prasad, Deo, S. V.S., Shrivastava, Anurag, Chitalkar, Prakash, Majumdar, Saroj Kumar, Vijay, Devanhalli, Thoke, Aniket, Udupa, K. S., Bajpai, Jyoti, Rath, G. K., Dattatreya, Palanki Satya, Bondarde, Shailesh, Patil, Shekhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719963/
https://www.ncbi.nlm.nih.gov/pubmed/34984198
http://dx.doi.org/10.1055/s-0041-1742080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719963/
https://www.ncbi.nlm.nih.gov/pubmed/34984198
http://dx.doi.org/10.1055/s-0041-1742080

Ejemplares similares